Influence of Manual Diaphragm Release Combined With Conventional Breathing Exercises and Prone Positioning on Pulmonary Functions in Women With COVID-19
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19 Pneumonia
- Sponsor
- Cairo University
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- forced vital capacity FVC
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Manual noninvasive respiratory techniques gained interest to treat respiratory pathologies related to COVID 19. This study designed to determine the combined effect of manual diaphragmatic release technique with the effect of conventional breathing exercises and prone positioning on pulmonary function parameters (FVC, FEV1, PEF, FEV1/FVC, FEF25, FEF50, FEF75, FEF25/75).
Detailed Description
Forty females were randomly assigned to two groups. Group A received manual diaphragm release with conventional breathing exercises and prone positioning. Group B received conventional breathing exercises and prone positioning. Both groups took their prescribed medications. Their ages ranged from 35 to 45 years and with moderate COVID-19 illness. Any cases with mild and severe COVID-19 illness, ICU admission, and chest diseases were excluded. Main measures: pulmonary function parameters (FVC, FEV1, PEF, FEV1/FVC, FEF25, FEF50, FEF75, FEF25/75).
Investigators
mona abd el raouf ghallab
lecturer at faculty of physical therapy
Cairo University
Eligibility Criteria
Inclusion Criteria
- •women with moderate COVID-19 illness diagnosed by a physician.
- •Patients with o2 saturation \>94%Nonsmoker subjects.
- •age ranging from 35-45 years.
- •body mass index from 25 to 34 kg/m2.
Exclusion Criteria
- •Unstable hemodynamic status.
- •Acute respiratory failure requiring intubation and impaired consciousness.
- •Inability to collaborate with prone positioning with refusal.
- •Change of mental status hindering response to instructions.
- •Poorly controlled hypertension (Mean systolic BP \> 140 mmhg and \\or diastolic BP \> 40 mmhg).
- •Patients who take continuous o2 supplementation.
- •Other chest diseases as (COPD-asthma-tuberculosis-cancer).
- •Male patients.
Outcomes
Primary Outcomes
forced vital capacity FVC
Time Frame: pre study and 3 weeks post study for all participants
the amount of air that can be forcibly exhaled from your lungs after taking the deepest breath possible which is a common breathing test to check lung function.
FEV1/FVC
Time Frame: pre study and 3 weeks post study for all participants
FEV1/FVC, also known as FEV1%) can help distinguish obstructive and restrictive lung diseases.
FEV1
Time Frame: pre study and 3 weeks post study for all participants
the maximum amount of air that the subject can forcibly expel during the first second following maximal inhalation
PEF
Time Frame: pre study and 3 weeks post study for all participants
show the amount and rate of air that can be forcefully breathed out of the lungs.
PEF25%
Time Frame: pre study and 3 weeks post study for all participants
Peak expiratory flow at 25% of fvc and the most sensitive measure of airflow in peripheral airways where primary airflow obstruction originates.
PEF50%
Time Frame: pre study and 3 weeks post study for all participants
Peak expiratory flow at 50% ofFVC
PEF 75%
Time Frame: pre study and 3 weeks post study for all participants
Peak expiratory flow at 75% of FVC
PEF 25%/75%
Time Frame: pre study and 3 weeks post study for all participants
Maximum flow rate in the middle 50% of forced expiration.